PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Recommendation of “Hold” by Brokerages
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has been assigned a consensus rating of “Hold” from the thirteen ratings firms that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the […]
More Stories
175 House Democrats Call for Halt to Ilhan Omar Investigation
By Guy Birchall Scores of House Democrats have called for an end to the federal investigation into Rep. Ilhan Omar...
Gas Prices, Housing, Interest Rates: Inside the US Cost-of-Living Picture Ahead of the Midterms
Andrew Moran, Kevin Stocklin and Emel Akan As voters weigh the economic records of both parties ahead of the midterms,...
2 Men Charged in UK Over Military Base Incident Allegedly Linked to Iran
By Rachel Roberts Two men were charged under the UK’s National Security Act on Oct. 27 over last month’s incident...
Trump Announces EPA Will Roll Back Biden-Era Methane Regulations on Oil and Gas Producers
By Tom Gantert President Donald Trump announced Tuesday night in Lubbock, Texas, that his administration would roll back Biden-era methane...
Treasury Department Ends Ownership Reporting for US Small Businesses
By Owen Evans The Treasury Department on Aug. 11 finalized a rule permanently exempting U.S. companies and individuals from reporting...
US Consumer Confidence Rebounds Sharply in October: Conference Board
By Andrew Moran U.S. consumer confidence rebounded sharply in October, logging its first increase in four months, according to The...